Alex Gilman, DO
Internal Medicine · Richmond, INNPI 1386608255
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,306 of the $22,561 with a category attached, or 76.7%. 9 manufacturers reported payments, led by Gilead at 42.8% of the total. Reporting peaked in 2021 at $5,930 and has fallen 90.8% since, to $548 in 2025. Among internal medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $663.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$10K
- Novo Nordisk$8K
- AstraZeneca$4K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$440
- Medtronic$139
- Vifor Pharma, Inc.$120
- plus $111 from 3 others
What the payments were for
- Consulting fees$17,30677%
- Speaking & faculty fees$2,19010%
- Travel & lodging$2,20110%
- Food & beverage$8654%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 17 | $9,655 |
| Novo Nordisk | 6 | $8,217 |
| AstraZeneca | 3 | $3,880 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $440 |
| Medtronic | 1 | $139 |
| Vifor Pharma, Inc. | 1 | $120 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $47 |
| Pfizer | 2 | $40 |
| Johnson & Johnson | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veklury$9,445
- IMFINZI$3,880
- SALEX$440
- CoreValve Evolut$139
- Veltassa$120
How this compares
$22,561 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 13 | $88 |
| Prednisone | 17 | $14 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Richmond
- Abhinav SinghGreenwood$733K
- Girish KunapareddyTerre Haute$329K
- Raj VuppalanchiIndianapolis$279K
- Joseph Arulandula Porte$251K
- Napoleon MamintaIndianapolis$116K
- Jennifer PaisleyLawrenceburg$112K
- Allon FriedmanIndianapolis$111K
- John AyresIndianapolis$107K
- Emily FrankLebanon$100K
- David IloFort Wayne$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.